Elucidating the Central Mechanism(s) of Action for Green Light Therapy in Managing Chronic Pain
NCT05569486·
NANOT_YET_RECRUITINGINTERVENTIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
A Phase II Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma of Soft Tissue
NCT07125183·
PHASE2RECRUITINGINTERVENTIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
A Feasibility Clinical Trial Assessing Patient Preference, Optimum Combinations and Sequences of a Multicomponent, Virtually-Delivered Migraine Behavioral Intervention
NCT06170281·
NANOT_YET_RECRUITINGINTERVENTIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
PREcision MEDicine In Achalasia - A Multicenter Randomized Non-Inferiority Clinical Trial of Short Tailored POEM vs. Standard POEM for Non-Spastic Achalasia and A Multicenter Prospective Cohort Study of Long Tailored POEM for Spastic Esophageal Motility Disorders
A Phase I Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
NCT06987318·
PHASE1NOT_YET_RECRUITINGINTERVENTIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma- R01 Aim 1a Renewal (SOS5C Trial)
NCT07206589·
NANOT_YET_RECRUITINGINTERVENTIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life
A Phase III, Parallel Design, Double-blind, Randomised, Placebo-controlled, Multi-centre Trial to Evaluate the Efficacy and Safety of Nerandomilast Oral Therapy Added to Standard Background Therapy Over 52 Weeks in Adult Trial Participants With Active Idiopathic Inflammatory Myopathies (VERANDA™-IIM)
Continued Pressure for Alveolar Protection: A Randomized Controlled Trial (CPAP Trial)
NCT07417111·
NARECRUITINGINTERVENTIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
NCT07292298·
PHASE2RECRUITINGINTERVENTIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
Subscalp Placement Of The LINQII Device: A First-in-human Device Feasibility Study
Efficacy and Safety of an Essential Oil-Based Product System for Digestive Support
NCT07653815·
NANOT_YET_RECRUITINGINTERVENTIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
Improved Detection and Localization Accuracy of Early Aggressive Prostate Adenocarcinoma Using Novel MR-directed Ultrasound-guided (MRdUSg) Prostate Biopsy Technique
NCT05064111·
SUSPENDEDOBSERVATIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
Metformin and Muscle Recovery Following ACL Surgery
NCT07699367·
EARLY_PHASE1NOT_YET_RECRUITINGINTERVENTIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
A Feasibility/Pilot First-in-human Study of Exercise-mobilized NK-enriched Donor Lymphocyte Infusions (DLI-X) to Prevent or Treat Leukemia Relapse After Allogeneic Hematopoietic Cell Transplantation
NCT07254793·
PHASE1NOT_YET_RECRUITINGINTERVENTIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of BMS-986511 in Two Sequential Parts in Participants With Major Depressive Disorder
Phase IV Study of the Pharmacokinetics of Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnant and Postpartum Women With HIV in the United States
NAC-REPAIR: N-Acetylcysteine-facilitated Redox-Immune Modulation for Post-surgical Analgesia and Injury Recovery
NCT07227649·
PHASE2NOT_YET_RECRUITINGINTERVENTIONAL
Sponsor: Sponsor not in directory
Source: ClinicalTrials.gov · Synced about 2 months ago
An Observational Pregnancy Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® (Inebilizumab-cdon) During Pregnancy